Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway

Dino Amadori, Patrizia Serra, Nestory Masalu, Akwilina Pangan, Emanuela Scarpi, Aloyce Maria Bugingo, Deogratias Katabalo, Toni Ibrahim, Alberto Bongiovanni, Giacomo Miserocchi, Chiara Spadazzi, Chiara Liverani, Valentina Turri, Rosanna Tedaldi, Laura Mercatali

Research output: Contribution to journalArticle

Abstract

As total vitamin D levels are often lower in black than in white Americans, the former are frequently classified as vitamin D-deficient. To fully understand African vitamin D (25(OH)D) status, other factors should be considered, e.g. vitamin D blood carrier, vitamin D-binding protein (DBP), vitamin D receptor (VDR) and DBP polymorphisms. A prospective study on an indigenous black Tanzanian and a Caucasian Italian population was performed on 50 healthy donors from both populations and 35 Caucasian and 18 African breast cancer patients. 25(OH)D and DBP serum levels were analyzed by ELISA. A1012G, Cdx2 and Fok1 VDR polymorphisms and DBP polymorphisms rs4588 and rs7041 were genotyped by real-time PCR. Vitamin D and DBP levels were lower in healthy African donors than in Caucasians. Africans had a significantly higher frequency of AA and CC for Cdx2 and Fok1 polymorphisms, respectively. These allelic variants were related to a higher transcription of VDR gene and a higher activity of VDR receptor. With regard to polymorphism distribution, Africans showed innate higher levels and activity of VDR. We conclude that a strengthening of the vitamin D pathway could have a protective role against the development of breast cancer in the African population.

Original languageEnglish
Pages (from-to)13142-13156
Number of pages15
JournalOncotarget
Volume8
Issue number8
DOIs
Publication statusPublished - Jan 1 2017

    Fingerprint

Keywords

  • 25(OH)D
  • Africans
  • Caucasians
  • Vitamin D binding protein
  • Vitamin D pathway

ASJC Scopus subject areas

  • Oncology

Cite this